Journal of Peking University(Health Sciences) ›› 2019, Vol. 51 ›› Issue (4): 748-752. doi: 10.19723/j.issn.1671-167X.2019.04.027

Previous Articles     Next Articles

Delayed diagnosis of oral squamous cell neoplasms at different sites

Tao XU,Dian-can WANG,Xiao-feng SHAN,Zhi-gang CAI()   

  1. Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China
  • Received:2017-08-22 Online:2019-08-18 Published:2019-09-03
  • Contact: Zhi-gang CAI E-mail:CZG4209@126.com

RICH HTML

  

Abstract:

Objective: To investigate the diagnostic delay of patients with oral squamous cell carcinoma by self-designed questionnaire to find out the significant influencing factors, so as to identify the influencing factors of the patient’s delay and the risk of oral cancer.Methods: A total of 514 patients with primary oral squamous cell carcinoma were enrolled at Peking University School and Hospital of Stomatology from January 2014 to April 2016, including 334 men and 180 women, with a male to female ratio of 1.85 :1. The youngest participant was 21 years old, with a maximum of 89 years and a median age of 57.6 years. The position of the disease according to International Classification of Diseases-10 (ICD-10) was divided into lip, buccal, gingival, retromolar, palate, floor of the mouth, tongue, and oropharynx. The age group is divided into 10 years. The level of education was divided into illiteracy, primary education level and advanced education level. Body mass index (BMI) was divided into three levels by 18 kg/m 2 and 25 kg/m 2. Visual analog scale (VAS) method was to evaluate the patient’s preoperative pain. At the same time, the patients were examined by detailed questionnaire to understand the delay factors and delay characteristics, and use SPSS 18.0 software, analysis of variance and chi-square test to explore correlation.Results: Among all patients, the proportion of patients developed in the tongue was the highest (43.3%). Delay was defined by a span of three months or longer from the onset of symptoms until treatment. The delays to diagnosis according to location were as follows (in months and in descending order): lip (6.1 months), buccal (4.1 months), floor of the mouth (3.9 months), tongue (3.6 months), oropharyngeal (2.9 months), retromolar (2.7 months), palatine (2.4 months), and gingival (2.4 months). Different sites and delayed diagnosis were statistically significant (P=0.048). There were no statistically significant differences in gender, education, pain, smoking, drinking and VAS score.Conclusion: The study has found that tumor positions and delay have a significant correlation. The position of the tumor is an obvious factor associated with the findings. The lip is the most likely to delay the diagnosis of oral positions. For the lip of the lesion, more than three months’ obvious mass is recommended for timely treatment, while at admission, physicians should take the appropriate diagnostic method as soon as possible.

Key words: Neoplasms, squamous cell, Delayed diagnosis, Mouth neoplasms

CLC Number: 

  • R739.8

Table 1

The delay characteristics of different factors of oral squamous cell carcinoma"

Items n (%) Delayed diagnosis P
No(<3 months) Yes(≥3 months)
Gender 0.759
Male 334 (65.0%) 241 (72.2%) 93 (27.8%)
Female 180 (35.0%) 127 (70.6%) 53 (29.4%)
Age 0.698
<40 years 52 (10.1%) 35(67.3%) 17(32.7%)
40-49 years 70 (13.6%) 50(71.4%) 20(28.6%)
50-59 years 147 (28.6%) 108(73.5%) 39(26.5%)
60-69 years 161 (31.3%) 110(68.3%) 51(31.7%)
70-79 years 79 (15.4%) 61(77.2%) 18(22.8%)
>79 years 5 (1.0%) 4(80.0%) 1(20.0%)
Education 0.267
Illiteracy 27 (5.3%) 23(85.2%) 4(14.8%)
Primary 309 (60.1%) 220(71.1%) 89(28.9%)
Advanced 178 (34.6%) 125(70.2%) 53(29.8%)
Smoking 0.762
Yes 273 (53.1%) 197(72.2%) 76(27.8%)
No 241 (46.9%) 171(70.9%) 70(29.1%)
Drinking 0.989
Yes 215 (41.8%) 154(71.6%) 61(28.4%)
No 299 (58.2%) 214(71.6%) 85(28.4%)
BMI 0.553
<18 kg/m2 28 (5.4%) 22(78.6%) 6(21.4%)
18-25 kg/m2 322 (62.6%) 226(70.2%) 96(29.8%)
>25 kg/m2 164 (31.9%) 120(73.2%) 44(26.8%)
VAS 0.971
0 43(8.4%) 31(72.1%) 12(27.9%)
1-3 239 (46.5%) 169(70.7%) 70(29.3%)
4-7 186 (36.2%) 134(72.1%) 52(27.9%)
7-10 46 (8.9%) 34(73.9%) 12(26.1%)
T stage 0.959
T1 98 (19.1%) 71(72.4%) 27(27.6%)
T2 192 (37.4%) 138(71.9%) 54(28.1%)
T3-4 224 (43.6%) 159(70.9%) 65(29.1%)
Position 0.048
Lip 21(4.1%) 14(66.7%) 7(33.3%)
Buccal 49(9.5%) 31(63.3%) 18(36.7%)
Gingival 111(21.6%) 92(82.9%) 19(17.1%)
Retromolar 14(2.7%) 11(78.6%) 3(21.4%)
Palatine 20(3.9%) 17(85.0%) 3(15.0%)
Floor of mouth 52(10.1%) 37(71.2%) 15(28.8%)
Tongue 223(43.4%) 150(67.3%) 73(32.7%)
Oropharyngeal 24(4.7%) 16(66.7%) 8(33.3%)

Table 2

Delayed diagnosis characteristics of different positions of oral squamous cell carcinoma"

Position n Number of delay diagnosis Time of medical history/months Time of delay diagnosis/months P
Lip 21 7(33.3%) 10.7±10.8 6.1±5.2 0.003
Buccal 49 18(36.7%) 7.1±6.5 4.1±4.6
Gingival 111 19(17.1%) 4.7±5.5 2.3±3.6
Retromolar 14 3(21.4%) 4.5±3.9 2.7±4.0
Palatine 20 3(15.0%) 3.7±3.2 2.4±3.3
Floor of mouth 52 15(28.8%) 6.2±6.5 3.9±5.9
Tongue 223 73(23.7%) 6.5±6.4 3.6±4.7
Oropharyngeal 24 8(33.3%) 5.3±5.0 2.9±3.2
[1] Gillison ML . Current topics in the epidemiology of oral cavity and oropharyngeal cancers[J]. Head Neck, 2007,29(8):779-792.
[2] Rogers SN, Brown JS, Woolgar JA , Survival following primary surgery for oral cancer[J]. Oral Oncol, 2009,45(3):201-211.
[3] Allison P, Franco E, Feine J . Predictors of professional diagnostic delays for upper aerodigestive tract carcinoma[J]. Oral Oncol, 1998,34(2):127-132.
[4] Cooke BE, Tapper-Jones L . Recognition of oral cancer. Causes of delay[J]. Br Dent J, 1977,142(3):96-98.
[5] Austoker J, Bankhead C, Forbes LJ , et al. Interventions to promote cancer awareness and early presentation: systematic review[J]. Br J Cancer, 2009,101(Suppl. 2):S31-S39.
[6] Peacock ZS, Pogrel MA, Schmidt BL . Exploring the reasons for delay in treatment of oral cancer[J]. J Am Dent Assoc, 2008,139(10):1346-1352.
[7] Jensen AR, Nellemann HM, Overgaard J . Tumor progression in waiting time for radiotherapy in head and neck cancer[J]. Radiother Oncol, 2007,84(1):5-10.
[8] Carvalho AL, Pintos J, Schlecht NF , et al. Predictive factors for diagnosis of advanced-stage squamous cell carcinoma of the head and neck[J]. Arch Otolaryngol Head Neck Surg, 2002,128(3):313-318.
[9] Seoane J, Varela-Centelles PI, Walsh TF , et al. Gingival squamous cell carcinoma: diagnostic delay or rapid invasion?[J]. J Periodontol, 2006,77(7):1229-1233.
[10] Goy J, Hall SF, Feldman-Stewart D , et al. Diagnostic delay and disease stage in head and neck cancer: a systematic review[J]. Laryngoscope, 2009,119(5):889-898.
[11] Thompson L . World Health Organization classification oftumours: pathology and genetics of head and neck tumors[J]. Ear Nose Throat J, 2006,85(2):74.
[12] 高巍, 郭传瑸 . 口腔鳞状细胞癌患者诊断延迟现象的研究现状[J]. 现代口腔医学杂志, 2008,22(4):419-423.
[13] Tong XJ, Shan ZF, Tang ZG , et al. Theimpact of clinical prognostic factors on the survival of patients with oral squamous cell carcinoma[J]. J Oral Maxillofac Surg, 2014,72(12):2497.
[14] Johnson NW, Jayasekara P, Amarasinghe AA . Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and etiology[J]. Periodontol 2000, 2011,57(1):19-37.
[15] Johnson NJ, Backlund E, Sorlie PD , et al. Marital status and mortality: the national longitudinal mortality study[J]. Ann Epide-miol, 2000,10(4):224-238.
[16] Rogers SN, Glen P, Robinson A , et al. A survey of general dental practitioners in merseyside regarding urgent appointments and suspected cancer referrals[J]. Prim Dent Care, 2008,15(1):25-30.
[17] Rogers RS . Common lesions of the oral mucosa. A guide to diseases of the lips, cheeks, tongue, and gingivae[J]. Postgrad Med, 1992,91(6):141-148.
[18] Koivunen P, Rantala N, Hyrynkangas K , et al. The impact of patient and professional diagnostic delays on survival in pharyngeal cancer[J]. Cancer, 2001,92(11):2885-2891.
[1] Zhicun LI, Tianyu WU, Lei LIANG, Yu FAN, Yisen MENG, Qian ZHANG. Risk factors analysis and nomogram model construction of postoperative pathological upgrade of prostate cancer patients with single core positive biopsy [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 896-901.
[2] Yuxuan TIAN,Mingjian RUAN,Yi LIU,Derun LI,Jingyun WU,Qi SHEN,Yu FAN,Jie JIN. Predictive effect of the dual-parametric MRI modified maximum diameter of the lesions with PI-RADS 4 and 5 on the clinically significant prostate cancer [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 567-574.
[3] Kaifeng YAO,Mingjian RUAN,Derun LI,Yuxuan TIAN,Yuke CHEN,Yu FAN,Yi LIU. Diagnostic efficacy of targeted biopsy combined with regional systematic biopsy in prostate cancer in patients with PI-RADS 4-5 [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 575-581.
[4] Junyong OU,Kunming NI,Lulin MA,Guoliang WANG,Ye YAN,Bin YANG,Gengwu LI,Haodong SONG,Min LU,Jianfei YE,Shudong ZHANG. Prognostic factors of patients with muscle invasive bladder cancer with intermediate-to-high risk prostate cancer [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 582-588.
[5] Junqi SU,Xiaoying WANG,Zhiqiang SUN. Establishment and verification of a prognostic nomogram for survival of tongue squamous cell carcinoma patients who underwent cervical dissection [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 120-130.
[6] Zi-xuan XUE,Shi-ying TANG,Min QIU,Cheng LIU,Xiao-jun TIAN,Min LU,Jing-han DONG,Lu-lin MA,Shu-dong ZHANG. Clinicopathologic features and prognosis of young renal tumors with tumor thrombus [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 802-811.
[7] Yi LIU,Chang-wei YUAN,Jing-yun WU,Qi SHEN,Jiang-xi XIAO,Zheng ZHAO,Xiao-ying WANG,Xue-song LI,Zhi-song HE,Li-qun ZHOU. Diagnostic efficacy of prostate cancer using targeted biopsy with 6-core systematic biopsy for patients with PI-RADS 5 [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 812-817.
[8] Min QIU,You-long ZONG,Bin-shuai WANG,Bin YANG,Chu-xiao XU,Zheng-hui SUN,Min LU,Lei ZHAO,Jian LU,Cheng LIU,Xiao-jun TIAN,Lu-lin MA. Treatment outcome of laparoscopic partial nephrectomy in patients with renal tumors of moderate to high complexity [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 833-837.
[9] Chang-wei YUAN,De-run LI,Zhi-hua LI,Yi LIU,Gang-zhi SHAN,Xue-song LI,Li-qun ZHOU. Application of dynamic contrast enhanced status in multiparametric magnetic resonance imaging for prostatic cancer with PI-RADS 4 lesion [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 838-842.
[10] Hui-li LIU,Yan-han LV,Xiao-xiao WANG,Min LI. Factors influencing the chronic post-surgical pain after laparoscopic surgery for elderly patients with urinary tract tumors [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 851-856.
[11] Zhong CAO,Hong-bing CEN,Jian-hong ZHAO,Jun MEI,Ling-zhi QIN,Wei LIAO,Qi-lin AO. Expression and significance of INSM1 and SOX11 in pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 575-581.
[12] Jian-xun MA,You-chen XIA,Bi LI,Hong-mei ZHAO,Yu-tao LEI,Xi BU. Choice of immediate breast reconstructive methods after modified radical mastectomy [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 612-618.
[13] Yu-xiao WU,Yi-fan KANG,Qian-ying MAO,Zi-meng LI,Xiao-feng SHAN,Zhi-gang CAI. Application of methylene blue near-infrared fluorescence imaging for oral sentinel lymph node mapping in rats [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 684-688.
[14] Shang XIE,Zhi-gang CAI,Xiao-feng SHAN. Application value of whole exon sequencing and immune related indicators in the precision treatment of oral squamous cell carcinoma [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 697-701.
[15] Han LU,Jian-yun ZHANG,Rong YANG,Le XU,Qing-xiang LI,Yu-xing GUO,Chuan-bin GUO. Clinical factors affecting the prognosis of lower gingival squamous cell carcinoma [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 702-707.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!